These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 24742294)

  • 1. The role of the TP73 gene and its transcripts in neuro-oncology.
    Jancalek R
    Br J Neurosurg; 2014 Oct; 28(5):598-605. PubMed ID: 24742294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
    Murray-Zmijewski F; Lane DP; Bourdon JC
    Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cell type-specific effect of TAp73 isoforms on the cell cycle and apoptosis.
    Holcakova J; Ceskova P; Hrstka R; Muller P; Dubska L; Coates PJ; Palecek E; Vojtesek B
    Cell Mol Biol Lett; 2008; 13(3):404-20. PubMed ID: 18350258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of p73 in malignancy: tumor suppressor or oncogene?
    Stiewe T; Pützer BM
    Cell Death Differ; 2002 Mar; 9(3):237-45. PubMed ID: 11859406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of N-terminally truncated variants of p73, deltaTAp73, in head and neck squamous cell cancer: a comparison with p53 mutations.
    Faridoni-Laurens L; Tourpin S; Alsafadi S; Barrois M; Temam S; Janot F; Koscielny S; Bosq J; Bénard J; Ahomadegbe JC
    Cell Cycle; 2008 Jun; 7(11):1587-96. PubMed ID: 18469517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo.
    Concin N; Becker K; Slade N; Erster S; Mueller-Holzner E; Ulmer H; Daxenbichler G; Zeimet A; Zeillinger R; Marth C; Moll UM
    Cancer Res; 2004 Apr; 64(7):2449-60. PubMed ID: 15059898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TAp73 and ΔNp73 have opposing roles in 5-aza-2'-deoxycytidine-induced apoptosis in breast cancer cells.
    Lai J; Yang F; Zhang W; Wang Y; Xu J; Song W; Huang G; Gu J; Guan X
    Mol Cells; 2014 Aug; 37(8):605-12. PubMed ID: 25134538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DeltaTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1.
    Domínguez G; García JM; Peña C; Silva J; García V; Martínez L; Maximiano C; Gómez ME; Rivera JA; García-Andrade C; Bonilla F
    J Clin Oncol; 2006 Feb; 24(5):805-15. PubMed ID: 16380414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p73 in apoptosis.
    Stiewe T; Pützer BM
    Apoptosis; 2001 Dec; 6(6):447-52. PubMed ID: 11595834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 Family isoforms.
    Bourdon JC
    Curr Pharm Biotechnol; 2007 Dec; 8(6):332-6. PubMed ID: 18289041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The functional domains in p53 family proteins exhibit both common and distinct properties.
    Harms KL; Chen X
    Cell Death Differ; 2006 Jun; 13(6):890-7. PubMed ID: 16543939
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of p73 activity by post-translational modifications.
    Conforti F; Sayan AE; Sreekumar R; Sayan BS
    Cell Death Dis; 2012 Mar; 3(3):e285. PubMed ID: 22419114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP53 family members and human cancers.
    Bénard J; Douc-Rasy S; Ahomadegbe JC
    Hum Mutat; 2003 Mar; 21(3):182-91. PubMed ID: 12619104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanism of p73-mediated regulation of hepatitis B virus core promoter/enhancer II: implications for hepatocarcinogenesis.
    Buhlmann S; Racek T; Schwarz A; Schaefer S; Pützer BM
    J Mol Biol; 2008 Apr; 378(1):20-30. PubMed ID: 18342333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.
    Concin N; Hofstetter G; Berger A; Gehmacher A; Reimer D; Watrowski R; Tong D; Schuster E; Hefler L; Heim K; Mueller-Holzner E; Marth C; Moll UM; Zeimet AG; Zeillinger R
    Clin Cancer Res; 2005 Dec; 11(23):8372-83. PubMed ID: 16322298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line.
    Goldschneider D; Blanc E; Raguénez G; Barrois M; Legrand A; Le Roux G; Haddada H; Bénard J; Douc-Rasy S
    J Cell Sci; 2004 Jan; 117(Pt 2):293-301. PubMed ID: 14676279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense gapmers selectively suppress individual oncogenic p73 splice isoforms and inhibit tumor growth in vivo.
    Emmrich S; Wang W; John K; Li W; Pützer BM
    Mol Cancer; 2009 Aug; 8():61. PubMed ID: 19671150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP73, an under-appreciated player in non-Hodgkin lymphoma pathogenesis and management.
    Hassan HM; Dave BJ; Singh RK
    Curr Mol Med; 2014 May; 14(4):432-9. PubMed ID: 24730526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells.
    Yu J; Baron V; Mercola D; Mustelin T; Adamson ED
    Cell Death Differ; 2007 Mar; 14(3):436-46. PubMed ID: 16990849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of p73 and p53 regulation and effector functions.
    Fang L; Lee SW; Aaronson SA
    J Cell Biol; 1999 Nov; 147(4):823-30. PubMed ID: 10562283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.